Article
HC Wainwright & Co. Reiterates Buy on Aardvark Therapeutics, Maintains $40 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Buy and maintains $40 price target.
Comments
- No comments yet. Be the first to comment!